nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—corpus luteum—testicular cancer	0.0796	0.192	CbGeAlD
Cyproterone acetate—AR—scrotum—testicular cancer	0.0768	0.185	CbGeAlD
Cyproterone acetate—CYP19A1—seminiferous tubule of testis—testicular cancer	0.0674	0.162	CbGeAlD
Cyproterone acetate—AR—seminiferous tubule of testis—testicular cancer	0.0597	0.144	CbGeAlD
Cyproterone acetate—CYP19A1—semen—testicular cancer	0.0373	0.0898	CbGeAlD
Cyproterone acetate—AR—semen—testicular cancer	0.033	0.0795	CbGeAlD
Cyproterone acetate—AR—seminal vesicle—testicular cancer	0.007	0.0169	CbGeAlD
Cyproterone acetate—CYP19A1—gonad—testicular cancer	0.00571	0.0138	CbGeAlD
Cyproterone acetate—NR3C1—embryo—testicular cancer	0.0054	0.013	CbGeAlD
Cyproterone acetate—NR3C1—seminal vesicle—testicular cancer	0.00507	0.0122	CbGeAlD
Cyproterone acetate—AR—gonad—testicular cancer	0.00506	0.0122	CbGeAlD
Cyproterone acetate—CYP19A1—female gonad—testicular cancer	0.00464	0.0112	CbGeAlD
Cyproterone acetate—CYP19A1—testis—testicular cancer	0.00412	0.00991	CbGeAlD
Cyproterone acetate—AR—female gonad—testicular cancer	0.00411	0.0099	CbGeAlD
Cyproterone acetate—NR3C1—gonad—testicular cancer	0.00366	0.00882	CbGeAlD
Cyproterone acetate—AR—testis—testicular cancer	0.00365	0.00878	CbGeAlD
Cyproterone acetate—CYP19A1—lymph node—testicular cancer	0.00298	0.00719	CbGeAlD
Cyproterone acetate—NR3C1—female gonad—testicular cancer	0.00298	0.00717	CbGeAlD
Cyproterone acetate—AR—lymph node—testicular cancer	0.00264	0.00636	CbGeAlD
Cyproterone acetate—NR3C1—testis—testicular cancer	0.00264	0.00636	CbGeAlD
Cyproterone acetate—NR3C1—lymph node—testicular cancer	0.00191	0.00461	CbGeAlD
Cyproterone acetate—Abdominal pain—Ifosfamide—testicular cancer	0.000534	0.000913	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—testicular cancer	0.000533	0.000912	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—testicular cancer	0.000529	0.000905	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—testicular cancer	0.000527	0.000902	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—testicular cancer	0.000526	0.000899	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Etoposide—testicular cancer	0.000522	0.000893	CcSEcCtD
Cyproterone acetate—Tachycardia—Etoposide—testicular cancer	0.000521	0.000891	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—testicular cancer	0.00052	0.000889	CcSEcCtD
Cyproterone acetate—Dyspnoea—Cisplatin—testicular cancer	0.000519	0.000888	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—testicular cancer	0.000518	0.000886	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—testicular cancer	0.000518	0.000885	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Etoposide—testicular cancer	0.000516	0.000882	CcSEcCtD
Cyproterone acetate—Pancreatitis—Epirubicin—testicular cancer	0.000516	0.000882	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—testicular cancer	0.000513	0.000877	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—testicular cancer	0.000509	0.00087	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—testicular cancer	0.000508	0.00087	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000507	0.000867	CcSEcCtD
Cyproterone acetate—Decreased appetite—Cisplatin—testicular cancer	0.000506	0.000866	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dactinomycin—testicular cancer	0.000504	0.000863	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000503	0.00086	CcSEcCtD
Cyproterone acetate—Vomiting—Bleomycin—testicular cancer	0.000502	0.000859	CcSEcCtD
Cyproterone acetate—Hypotension—Etoposide—testicular cancer	0.000498	0.000853	CcSEcCtD
Cyproterone acetate—Rash—Bleomycin—testicular cancer	0.000498	0.000852	CcSEcCtD
Cyproterone acetate—Dermatitis—Bleomycin—testicular cancer	0.000498	0.000852	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Ifosfamide—testicular cancer	0.000498	0.000851	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000496	0.000849	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—testicular cancer	0.000496	0.000849	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—testicular cancer	0.000492	0.000842	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—testicular cancer	0.000487	0.000832	CcSEcCtD
Cyproterone acetate—Pollakiuria—Epirubicin—testicular cancer	0.000486	0.000831	CcSEcCtD
Cyproterone acetate—Asthenia—Ifosfamide—testicular cancer	0.000485	0.000829	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—testicular cancer	0.00048	0.000822	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—testicular cancer	0.00048	0.000821	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Cisplatin—testicular cancer	0.00048	0.000821	CcSEcCtD
Cyproterone acetate—Weight increased—Epirubicin—testicular cancer	0.000479	0.000819	CcSEcCtD
Cyproterone acetate—Pruritus—Ifosfamide—testicular cancer	0.000478	0.000817	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—testicular cancer	0.000478	0.000817	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—testicular cancer	0.000477	0.000816	CcSEcCtD
Cyproterone acetate—Weight decreased—Epirubicin—testicular cancer	0.000476	0.000814	CcSEcCtD
Cyproterone acetate—Dyspnoea—Etoposide—testicular cancer	0.000476	0.000813	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Epirubicin—testicular cancer	0.000474	0.000811	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—testicular cancer	0.000474	0.00081	CcSEcCtD
Cyproterone acetate—Nausea—Bleomycin—testicular cancer	0.000469	0.000803	CcSEcCtD
Cyproterone acetate—Vomiting—Dactinomycin—testicular cancer	0.000469	0.000802	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—testicular cancer	0.000465	0.000795	CcSEcCtD
Cyproterone acetate—Decreased appetite—Etoposide—testicular cancer	0.000464	0.000793	CcSEcCtD
Cyproterone acetate—Diarrhoea—Ifosfamide—testicular cancer	0.000462	0.00079	CcSEcCtD
Cyproterone acetate—Renal failure—Epirubicin—testicular cancer	0.000461	0.000788	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000461	0.000788	CcSEcCtD
Cyproterone acetate—Body temperature increased—Cisplatin—testicular cancer	0.00046	0.000787	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—testicular cancer	0.00046	0.000787	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—testicular cancer	0.000457	0.000782	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—testicular cancer	0.000456	0.00078	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—testicular cancer	0.000452	0.000773	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—testicular cancer	0.00045	0.000769	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—testicular cancer	0.00045	0.000769	CcSEcCtD
Cyproterone acetate—Sweating—Epirubicin—testicular cancer	0.000449	0.000769	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—testicular cancer	0.000449	0.000769	CcSEcCtD
Cyproterone acetate—Haematuria—Epirubicin—testicular cancer	0.000447	0.000765	CcSEcCtD
Cyproterone acetate—Dizziness—Ifosfamide—testicular cancer	0.000447	0.000764	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000444	0.00076	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—testicular cancer	0.000443	0.000758	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—testicular cancer	0.000443	0.000757	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—testicular cancer	0.00044	0.000753	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—testicular cancer	0.00044	0.000752	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—testicular cancer	0.000439	0.000751	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—testicular cancer	0.000438	0.000749	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—testicular cancer	0.000436	0.000746	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—testicular cancer	0.000433	0.000741	CcSEcCtD
Cyproterone acetate—Vomiting—Ifosfamide—testicular cancer	0.000429	0.000735	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Cisplatin—testicular cancer	0.000429	0.000734	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—testicular cancer	0.000426	0.000729	CcSEcCtD
Cyproterone acetate—Rash—Ifosfamide—testicular cancer	0.000426	0.000728	CcSEcCtD
Cyproterone acetate—Dermatitis—Ifosfamide—testicular cancer	0.000425	0.000728	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—testicular cancer	0.000425	0.000727	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—testicular cancer	0.000424	0.000725	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—testicular cancer	0.000423	0.000724	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—testicular cancer	0.000423	0.000723	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—testicular cancer	0.000422	0.000721	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—testicular cancer	0.000422	0.000721	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—testicular cancer	0.000421	0.00072	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—testicular cancer	0.000421	0.00072	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—testicular cancer	0.00042	0.000719	CcSEcCtD
Cyproterone acetate—Asthenia—Cisplatin—testicular cancer	0.000418	0.000715	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—testicular cancer	0.000416	0.000711	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—testicular cancer	0.000414	0.000707	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—testicular cancer	0.000414	0.000707	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00041	0.000702	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—testicular cancer	0.000408	0.000698	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—testicular cancer	0.000406	0.000695	CcSEcCtD
Cyproterone acetate—Visual impairment—Epirubicin—testicular cancer	0.000406	0.000694	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—testicular cancer	0.000405	0.000693	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—testicular cancer	0.000404	0.00069	CcSEcCtD
Cyproterone acetate—Nausea—Ifosfamide—testicular cancer	0.000401	0.000686	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cisplatin—testicular cancer	0.000398	0.000681	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Epirubicin—testicular cancer	0.000398	0.000681	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—testicular cancer	0.000397	0.00068	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—testicular cancer	0.000394	0.000674	CcSEcCtD
Cyproterone acetate—Eye disorder—Epirubicin—testicular cancer	0.000393	0.000673	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—testicular cancer	0.000393	0.000672	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—testicular cancer	0.000392	0.00067	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—testicular cancer	0.000391	0.000669	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—testicular cancer	0.000389	0.000666	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—testicular cancer	0.000389	0.000666	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—testicular cancer	0.000383	0.000655	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000383	0.000655	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—testicular cancer	0.000382	0.000653	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—testicular cancer	0.00038	0.00065	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—testicular cancer	0.000379	0.000649	CcSEcCtD
Cyproterone acetate—Chills—Epirubicin—testicular cancer	0.000378	0.000646	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—testicular cancer	0.000377	0.000646	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—testicular cancer	0.000375	0.000642	CcSEcCtD
Cyproterone acetate—Alopecia—Epirubicin—testicular cancer	0.000372	0.000636	CcSEcCtD
Cyproterone acetate—Vomiting—Cisplatin—testicular cancer	0.00037	0.000633	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—testicular cancer	0.000369	0.000631	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—testicular cancer	0.000368	0.00063	CcSEcCtD
Cyproterone acetate—Rash—Cisplatin—testicular cancer	0.000367	0.000628	CcSEcCtD
Cyproterone acetate—Dermatitis—Cisplatin—testicular cancer	0.000367	0.000627	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—testicular cancer	0.000366	0.000627	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—testicular cancer	0.000365	0.000624	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—testicular cancer	0.000364	0.000622	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—testicular cancer	0.000363	0.000621	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—testicular cancer	0.000362	0.000619	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—testicular cancer	0.00036	0.000615	CcSEcCtD
Cyproterone acetate—Angiopathy—Doxorubicin—testicular cancer	0.000353	0.000604	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—testicular cancer	0.000353	0.000604	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—testicular cancer	0.000353	0.000603	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—testicular cancer	0.000352	0.000602	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000351	0.0006	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—testicular cancer	0.00035	0.000599	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—testicular cancer	0.000349	0.000598	CcSEcCtD
Cyproterone acetate—Nausea—Cisplatin—testicular cancer	0.000346	0.000592	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—testicular cancer	0.000344	0.000589	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—testicular cancer	0.000342	0.000584	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—testicular cancer	0.000341	0.000584	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—testicular cancer	0.00034	0.000581	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—testicular cancer	0.000339	0.00058	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—testicular cancer	0.000339	0.00058	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—testicular cancer	0.000339	0.000579	CcSEcCtD
Cyproterone acetate—Agitation—Epirubicin—testicular cancer	0.000337	0.000576	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—testicular cancer	0.000336	0.000575	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—testicular cancer	0.000336	0.000575	CcSEcCtD
Cyproterone acetate—Headache—Etoposide—testicular cancer	0.000334	0.000572	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—testicular cancer	0.000333	0.000569	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000331	0.000566	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—testicular cancer	0.00033	0.000565	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—testicular cancer	0.000329	0.000563	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—testicular cancer	0.000329	0.000562	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—testicular cancer	0.000328	0.000561	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Epirubicin—testicular cancer	0.000322	0.000551	CcSEcCtD
Cyproterone acetate—Cough—Epirubicin—testicular cancer	0.00032	0.000547	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—testicular cancer	0.000317	0.000542	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000315	0.000538	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—testicular cancer	0.000313	0.000536	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—testicular cancer	0.000313	0.000536	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—testicular cancer	0.000313	0.000535	CcSEcCtD
Cyproterone acetate—Agitation—Doxorubicin—testicular cancer	0.000312	0.000533	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—testicular cancer	0.00031	0.000531	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00031	0.00053	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—testicular cancer	0.000309	0.000528	CcSEcCtD
Cyproterone acetate—Discomfort—Epirubicin—testicular cancer	0.000308	0.000527	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—testicular cancer	0.000306	0.000523	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—testicular cancer	0.000305	0.000521	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—testicular cancer	0.000304	0.00052	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—testicular cancer	0.000303	0.000519	CcSEcCtD
Cyproterone acetate—Oedema—Epirubicin—testicular cancer	0.000299	0.000511	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—testicular cancer	0.000299	0.000511	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—testicular cancer	0.000298	0.00051	CcSEcCtD
Cyproterone acetate—Cough—Doxorubicin—testicular cancer	0.000296	0.000506	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—testicular cancer	0.000294	0.000503	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Epirubicin—testicular cancer	0.000293	0.000502	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—testicular cancer	0.000293	0.000501	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—testicular cancer	0.000292	0.000499	CcSEcCtD
Cyproterone acetate—Skin disorder—Epirubicin—testicular cancer	0.00029	0.000497	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Epirubicin—testicular cancer	0.000289	0.000494	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000287	0.00049	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—testicular cancer	0.000285	0.000488	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—testicular cancer	0.000285	0.000488	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—testicular cancer	0.000285	0.000487	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—testicular cancer	0.000281	0.000481	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—testicular cancer	0.000279	0.000478	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—testicular cancer	0.000278	0.000475	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—testicular cancer	0.000277	0.000473	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000276	0.000472	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—testicular cancer	0.000275	0.000471	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—testicular cancer	0.000272	0.000466	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—testicular cancer	0.000271	0.000464	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000271	0.000463	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—testicular cancer	0.00027	0.000462	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—testicular cancer	0.000269	0.00046	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000267	0.000457	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—testicular cancer	0.000267	0.000456	CcSEcCtD
Cyproterone acetate—Anorexia—Doxorubicin—testicular cancer	0.000264	0.000451	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—testicular cancer	0.000263	0.00045	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—testicular cancer	0.000263	0.00045	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000261	0.000447	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—testicular cancer	0.00026	0.000445	CcSEcCtD
Cyproterone acetate—Hypotension—Doxorubicin—testicular cancer	0.000259	0.000442	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000258	0.000442	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—testicular cancer	0.000258	0.000441	CcSEcCtD
Cyproterone acetate—Constipation—Epirubicin—testicular cancer	0.000256	0.000437	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—testicular cancer	0.000254	0.000434	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—testicular cancer	0.000253	0.000432	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—testicular cancer	0.000253	0.000432	CcSEcCtD
Cyproterone acetate—Dyspnoea—Doxorubicin—testicular cancer	0.000247	0.000422	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—testicular cancer	0.000246	0.000421	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000245	0.000418	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—testicular cancer	0.000244	0.000417	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—testicular cancer	0.000241	0.000411	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000239	0.000409	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—testicular cancer	0.000239	0.000408	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—testicular cancer	0.000238	0.000406	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—testicular cancer	0.000237	0.000405	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—testicular cancer	0.000236	0.000404	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—testicular cancer	0.000236	0.000404	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—testicular cancer	0.000235	0.000403	CcSEcCtD
Cyproterone acetate—Asthenia—Methotrexate—testicular cancer	0.000229	0.000392	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Doxorubicin—testicular cancer	0.000228	0.00039	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000226	0.000387	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—testicular cancer	0.000226	0.000387	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Epirubicin—testicular cancer	0.00022	0.000377	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—testicular cancer	0.00022	0.000376	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—testicular cancer	0.000219	0.000374	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—testicular cancer	0.000219	0.000374	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—testicular cancer	0.000219	0.000374	CcSEcCtD
Cyproterone acetate—Asthenia—Epirubicin—testicular cancer	0.000215	0.000367	CcSEcCtD
Cyproterone acetate—Pruritus—Epirubicin—testicular cancer	0.000212	0.000362	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—testicular cancer	0.000211	0.000361	CcSEcCtD
Cyproterone acetate—Diarrhoea—Epirubicin—testicular cancer	0.000205	0.00035	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—testicular cancer	0.000204	0.000349	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—testicular cancer	0.000203	0.000347	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—testicular cancer	0.000201	0.000345	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—testicular cancer	0.000201	0.000344	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—testicular cancer	0.0002	0.000342	CcSEcCtD
Cyproterone acetate—Asthenia—Doxorubicin—testicular cancer	0.000199	0.00034	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—testicular cancer	0.000198	0.000338	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—testicular cancer	0.000196	0.000335	CcSEcCtD
Cyproterone acetate—Vomiting—Epirubicin—testicular cancer	0.00019	0.000325	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—testicular cancer	0.00019	0.000325	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—testicular cancer	0.000189	0.000324	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—testicular cancer	0.000189	0.000322	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—testicular cancer	0.000188	0.000322	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—testicular cancer	0.000187	0.00032	CcSEcCtD
Cyproterone acetate—Dizziness—Doxorubicin—testicular cancer	0.000183	0.000313	CcSEcCtD
Cyproterone acetate—Nausea—Epirubicin—testicular cancer	0.000178	0.000304	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—testicular cancer	0.000176	0.000301	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—testicular cancer	0.000174	0.000298	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—testicular cancer	0.000174	0.000298	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—testicular cancer	0.000173	0.000296	CcSEcCtD
Cyproterone acetate—Nausea—Doxorubicin—testicular cancer	0.000164	0.000281	CcSEcCtD
